DeutschNewstral
Article
Ddcourier.com on 2024-03-19 07:37
Analyst revamps Eli Lilly stock price target on weight loss drug
Related news
- DAnalysts revamp Eli Lilly stock price target on weight-loss drugsdcourier.com
- DAnalyst revamps GE stock price target after investor daysdcourier.com
- BEli Lilly Stock Falls as Sales Disappoint. Analyst Welcomes Diabetes Data.barrons.com
- MPfizer enters weight reduction drug market with Novo Nordisk, Eli Lillymvtelegraph.com
- DEli Lilly leaps as weight-loss-drug sales drive earnings and 2024 outlookdcourier.com
- DAnalyst revamps Netflix stock price target after analyst surveydcourier.com
Soaring sales of diabetes drug Mounjaro, widely used for weight loss, sends Eli Lilly to new heightsseattletimes.com- BEli Lilly Stock Rises as Earnings Guidance Beats Analyst Expectationsbarrons.com
Eli Lilly & Co: Eli Lilly to invest extra $5.3bn in manufacturing site for weight loss drugsFinancial Times- Eli Lilly & Co: Eli Lilly to seek obesity drug approval that could disrupt weight loss marketFinancial Times
- Eli Lilly & Co: Eli Lilly weight-loss drug found to address sleep apnoea in trialFinancial Times
- DAnalyst revamps MicroStrategy stock price target after Bitcoin buydcourier.com
- DAnalyst who predicted Amazon stock could eclipse $200 revamps targetdcourier.com
- TAnalyst who correctly predicted Tesla’s stock drop revamps targetthestreet.com
- TAnalyst revamps Ford stock-price target after earningsthestreet.com
- DAnalyst who correctly predicted Tesla's stock drop revamps targetdcourier.com
- DAnalyst revamps Coke stock price target after strategic movesdcourier.com
- DTop analyst revamps Tesla price target, sees potential profit surprisedcourier.com